Rationale for Trials Studying Pegylated Liposomal Doxorubicin in Metastatic Breast Cancer
ByMohammad Jahanzeb, MD,Cynthia Frankel, RN,Mohammed Elkersh, MD,Alan Koletsky, MD,Peter Radice, MD,Charles L. Vogel, MD, FACP
Published: | Updated:
Breast cancer is second only to lung cancer as a leading cause of cancer mortality in women. In women with metastatic, hence, essentially incurable disease, we strive to find effective chemotherapeutic regimens that offer a